Dean Rebouche pushes back against the “widespread conflation of discretion and defiance” regarding the FDA’s enforcement discretion should its approval of mifepristone be rolled back.
Published on May 23, 2023
Abortion Pill Legal Fight Leaves FDA Grappling With Response
